🇰🇷 Ngenla in South Korea

Ngenla (Somatrogon-Ghla) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Status: likely_approved

Ngenla in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Metabolic approved in South Korea

Frequently asked questions

Is Ngenla approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for Ngenla in South Korea?

Pfizer Ireland Pharmaceuticals is the originator. The local marketing authorisation holder may differ — check the official source linked above.